Biotech · Private company
NLS Pharmaceutics
Track this companyFree. Adds NLS Pharmaceutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MazindolPhase 2 · Narcolepsy With CataplexyClinicalTrials.gov · fetched Nov 12, 2026
- mazindol extended releasePhase 2 · NarcolepsyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With NarcolepsyPHASE2 · COMPLETED · started Oct 26, 2021ClinicalTrials.gov NCT05055024 · fetched Nov 12, 2026
- Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of NarcolepsyPHASE2 · COMPLETED · started Sep 13, 2021ClinicalTrials.gov NCT04923594 · fetched Nov 12, 2026